MIAMI, Oct. 26, 2015—Global Stem Cells Group has announced that Alfredo Hoyos, M.D., head of the Global Stem Cells Group Faculty, will be keynote speaker at the 2nd Aesthetic & Anti-aging Medicine World Congress (AMWC) – Latin America, to be held in Medellin, Colombia Nov. 5, 6 and 7, 2015. The conference will focus on aesthetic dermatology and surgery, preventive and anti-aging medicine.
Hoyos, founder of and the inventor of High Definition Liposculpture (HDL), Dynamic Definition Lipoplasty (4D), and other advanced techniques in body contouring, will present his curriculum, “Advanced Liposuction 4D: Evolution and State of the Art state-of-the-art Techniques,” combining VASER technology with other techniques. Hoyos will also be participating in the event’s half-day program dedicated to body contouring through liposuction surgery.

The conference will be a one-of-a-kind event, the largest international event in the field of aesthetic and anti-aging medicine, designed to showcase AWMC Latin America’s commitment to innovation, expertise and excellence by sharing a wealth of experience as well as teaching skills to medical professionals from around the world. The conference’s prestigious lineup of international faculty members will contribute to the enhancement of knowledge and skills for all attending practitioners.
The conference will offer a number of advanced academic and clinical sessions with lectures presented by prominent experts in the field of aesthetic and anti-aging medicine as well as from research centers and universities. Maritza Novas, R.N., M.S.N., lead trainer with GSCG subsidiary Stem Cells Training, will speak on the use of fat stem cells for tissue regeneration.

Participants will have an opportunity to meet representatives from companies and manufacturers in the medical industry during breaks offered on site. A large exhibition will showcase the services and products of leading aesthetic and anti-aging professionals and companies from around the world.
The 2nd AMWC – Aesthetic & Anti-Aging Medicine World Congress – Latin America will be held at the Main Square Convention Center (Plaza Mayor Convenciones) in Medellion. For more information, visit the AMWC website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.

About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.

About Alfredo Hoyos, M.D.:
Alfredo Hoyos, M.D., has been an active member of the GSCG team since signing on as an exclusive representative for the stem cell leader’s Colombian territory in Sept., 2014. Hoyos was named the permanent head of the GSCG Faculty in Oct., 2015.

The Global Stem Cells Group / Stem Cell Training Faculty consists of a distinguished board of physicians, all experts in stem cell and regenerative medicine. The faculty reviews, updates and makes decision pertaining to the training programs offered through the Stem Cell Training division of Global Stem Cells Group. Faculty members also share the latest hand-on techniques and technologies with physicians, nurses, and other health care professionals through SCT’s instructional stem cell training courses.

Hoyos divides his time between practices in Miami and Bogota, Colombia. He is the founder of Stemlab, a Bogota, Colombia company dedicated to furthering the development of aesthetic techniques using stem cell (stromal) derived from adipose tissue. Stemlab is currently conducting extensive research in regenerative medicine in an effort to establish stem cell treatments that can repair damaged tissue in living organisms, using natural biological mechanisms that are proving useful in auto repair processes on damaged tissue.

About Maritza Novas, R.N., M.S.N.:
Maritza Novas, R.N., M.S.N. is the lead trainer and member member of the research and development of Stem Cell Training, a subsidiary of Global Stem Cells Group, specializing in:
•  Functional medicine
•  Age management
•  Bio-identical hormone therapy
•  Weight control
•  Rejuvenation.

A certified Adistem Specialist for more than four years, Ms. Novas has performed more than 600 treatments involving a range of pathologies.

Novas has been responsible for successfully training and certifying more than 150 stem cell practitioners globally, and has assisted in the development of new proprietary adipose and bone marrow protocols currently being used in Stem Cell Training Inc. comprehensive courses. She is a member of the American Academy of Anti-aging Medicine.

Previous Post
Global Stem Cells Group to Share Latest Stem Cell Harvesting Techniques at 20th World Congress of Aesthetic Medicine in Miami
Next Post
Global Stem Cells group Launches New Clinical Site in Cochabamba, Bolivia

Latest posts